Welcome to LookChem.com Sign In|Join Free
  • or
HEMICHOLINIUM-15 is a chemical compound that selectively and potently inhibits the high-affinity choline transporter, thereby blocking choline uptake into cells. This action results in a reduction of acetylcholine synthesis and release, affecting cholinergic neurotransmission.
Used in Research Applications:
HEMICHOLINIUM-15 is used as a research tool for studying the role of choline uptake in various physiological processes and its potential therapeutic applications.
Used in Pharmaceutical Research:
HEMICHOLINIUM-15 is used as a compound in the development of potential treatments for conditions such as Alzheimer's disease and other neurological disorders, given its impact on cholinergic neurotransmission.
Used in Clinical Research:
Although its use in clinical settings is limited due to its potency and potential side effects on cholinergic function, HEMICHOLINIUM-15 is still utilized in clinical research to explore its therapeutic potential and safety profile.

4303-88-2

Post Buying Request

4303-88-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4303-88-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4303-88-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,0 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 4303-88:
(6*4)+(5*3)+(4*0)+(3*3)+(2*8)+(1*8)=72
72 % 10 = 2
So 4303-88-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H18NO2.BrH/c1-13(2)8-9-15-12(14,10-13)11-6-4-3-5-7-11;/h3-7,14H,8-10H2,1-2H3;1H/q+1;/p-1

4303-88-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,4-dimethyl-2-phenylmorpholin-4-ium-2-ol,bromide

1.2 Other means of identification

Product number -
Other names hemicholinium-15

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4303-88-2 SDS

4303-88-2Relevant academic research and scientific papers

Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart

Gao, Mingzhang,Miller, Michael A.,DeGrado, Timothy R.,Mock, Bruce H.,Lopshire, John C.,Rosenberger, Joshua G.,Dusa, Cristian,Das, Mithilesh Kumar,Groh, William J.,Zipes, Douglas P.,Hutchins, Gary D.,Zheng, Qi-Huang

, p. 1289 - 1297 (2008/09/17)

[11C]Hemicholinium-15 ([11C]HC-15) and [18F]hemicholinium-15 ([18F]HC-15) have been synthesized as new potential PET tracers for the heart high-affinity choline uptake (HACU) system. [11C]HC-15 was prepared by N-[11C]methylation of the appropriate precursor, 4-methyl-2-phenyl-morpholin-2-ol, using [11C]CH3OTf in 55-70% radiochemical yield decay corrected to end of bombardment (EOB) and 2-3 Ci/μmol specific activity at end of synthesis (EOS). [18F]HC-15 was prepared by N-[18F]fluoromethylation of the precursor using [18F]FCH2OTf in 20-30% radiochemical yield decay corrected to EOB and >1.0 Ci/μmol specific activity at EOS. The biodistribution of both compounds was determined in rats at 20 min post-intravenous injection, and the results show the heart region uptakes 1.32 ± 0.75%ID/g in R-ventricle for [11C]HC-15 and 1.28 ± 0.81%ID/g in L-ventricle for [18F]HC-15, respectively. The dynamic PET imaging studies of [11C]HC-15 in rats were acquired 60 min post-intravenous injection of the tracer using the IndyPET-II scanner. For the blocking experiments, the rats were intravenously pretreated with 3.0 mg/kg of unlabeled HC-15 prior to [11C]HC-15 injection. [11C]HC-15 rat heart PET studies show rapid heart uptake to give clear heart images. The rat heart PET blocking studies found no significant blocking effect. The dynamic PET studies in normal and ablated dogs were performed using Siemens PET scanner with [13N]NH3, [11C]HC-15, and [18F]HC-15. PET studies in dogs of both [11C]HC-15 and [18F]HC-15 also show significant heart uptake and give images of the heart. However, there is no significant change in [11C]HC-15 L-ventricle uptake following radiofrequency ablation in the dog. These results suggest that the localization of HC-15 tracers in the heart is mediated by non-specific processes, and the visualization of HC-15 tracers on the heart is related to non-specific binding of HACU.

Synthesis, physicochemical properties and biological studies of some substituted 2-alkoxy-4-methyl-morpholines

Rekka, Eleni,Kourounakis, Panos

, p. 179 - 184 (2007/10/02)

The title compounds have some structural characteristic of the piperidine-type analgesics and central sympathomimetics.The synthesis of some substituted 2-hydroxy- and 2-alkoxy-4-methyl-morpholines is presented and studied, in terms of electronic and steric effects.Their log P and pKa values were determined and are explained in terms of structural, stereochemical and electronic effects.Acute toxicity and, for some selected cases, anti-nociceptive and central sympathomimetic activities have been evaluated in a preliminary (QSAR) study of biological properties of the synthesized compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4303-88-2